LEONARD TREANOR: Open Payments
NPI 1487823506 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,122 in 92 payments from 22 companies in 2025. Trend: 2023 $5,790 · 2024 $8,182 · 2025 $5,122
Food & beverage: $2,763Speaker / faculty: $2,250Education: $109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $2,712 |
| Novo Nordisk Inc | 6 | $407 |
| Teva Pharmaceuticals USA, Inc. | 12 | $288 |
| ABBVIE INC. | 6 | $259 |
| Stryker Corporation | 2 | $248 |
| Janssen Pharmaceuticals, Inc | 2 | $208 |
| Otsuka America Pharmaceutical, Inc. | 5 | $194 |
| Amgen Inc. | 30 | $156 |
| Teleflex LLC | 1 | $146 |
| Axsome Therapeutics, Inc. | 1 | $119 |
Products named: AIRSUPRA, Ozempic, REXULTI, FARXIGA, SPRAVATO, AUSTEDO XR, Wegovy, UROLIFT.
Industry payments across LA — which companies pay providers there.
